Esab India Ltd
ESABINDIAEsab India Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is already 15 weeks into its uptrend — timing risk, not thesis risk.
The price is in a confirmed uptrend (15 weeks in) while the P/E sits at the 60th percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +36.6% year on year, and 96% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Esab India Ltd trades at ₹6,232, in a confirmed uptrend and 15 weeks into that stage. That is +8.8% against its own 200-day average. It sits at 64% of a 52-week range of ₹4,762 to ₹7,053. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week.
Today the stock is in a confirmed uptrend — week 15 of stage 2. At ₹6,232 it trades +8.8% versus its 200-day average and sits at 64% of its 52-week range (₹4,762–₹7,053).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +913% while the NIFTY 500 moved +270% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Esab India Ltd trades at 46.3× P/E, mid-range by its own standards (60th percentile). Its long-run median P/E is 43.7×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 46.3× is mid-range by its own standards (60th percentile), against a long-run median of 43.7× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +17.8% against a +24.4% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +26.5%/yr price move, ~+23.4%/yr came from earnings growth and ~+3.1 pp from the multiple (expanding); over 10y, of the +26.9%/yr price move, ~+20.5%/yr came from earnings growth and ~+6.4 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Esab India Ltd reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 66.7% and holding. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +9.8% | +11.4% | +17.2% | +12.8% |
| Profit | +18.3% | +15.0% | +28.5% | +22.1% |
| EPS | +17.8% | +15.1% | +28.4% | +22.0% |
| Share price | +24.4% | +8.5% | +26.5% | +26.9% |
4-Factor Sector Score
51.4/100 — rank 3 of 3 in Welding Equipments · 97% evidence confidence
Esab India Ltd scores 51.4 out of 100 against the 3 companies it is compared with in Welding Equipments, ranking 3. Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
The four contributions add to the total exactly: 22.1 + 19.7 + 4.6 + 5 = 51.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Esab India Ltd reported ₹421 Cr of revenue in the Jun 26 quarter, +19.6% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 12.8% a year. The last full year, FY26, came in at ₹1,508 Cr. The last four reported quarters add to ₹1,578 Cr.
FY26 revenue came in at ₹1,508 Cr (+9.8% on the year), capping 10 years at 12.8% compound. The latest quarter (Jun 26) printed ₹421 Cr, +19.6% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +13.1% growth against the decade's 12.8% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +13.0% over the last 4 quarters against +11.2%/yr over the last 8 — stabilising; TTM profit +29.8% vs +16.3%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Esab India Ltd's operating margin is 19.0% in the Jun 26 quarter, +2.0 percentage points against the same quarter a year ago. Across 16 fiscal years the operating margin has ranged 8.0% to 24.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 19.0%, +2.0 pp against the same quarter a year ago. Across 16 fiscal years the operating margin has ranged 8.0%–24.0%.
Why the margin moved: operating margin went +2.0 pp year on year while gross margin went +0.6 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Esab India Ltd earned ₹56.0 Cr of net profit in the Jun 26 quarter, +36.6% year on year. Full-year FY26 profit was ₹207 Cr. The 10-year compound rate is 22.1%. That is 13.3% of the quarter's revenue. The same quarter a year earlier earned ₹41.0 Cr.
Jun 26 profit was ₹56.0 Cr, +36.6% year on year. On the full year, FY26 printed ₹207 Cr (+18.3%), and the 10-year compound rate is 22.1%.
Why profit moved: revenue contributed +19.6% and the margin +2.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +30.4% vs revenue +13.1%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 96% of Esab India Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹181 Cr of operating cash against ₹207 Cr of profit. After ₹26.0 Cr of capital spending, ₹155 Cr was left as free cash.
FY26: operating cash of ₹181 Cr against reported profit of ₹207 Cr, leaving free cash of ₹155 Cr after ₹26.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 96% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 96%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: the bigger cash user is investment — capital spending ran 1.8× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Esab India Ltd's cash conversion cycle runs 34 days in FY26, down from 34 days in FY21. Capital spending ran ₹85.0 Cr over the last 3 years. At FY26 sales of ₹1,508 Cr each day of that cycle holds about ₹4.1 Cr, so roughly ₹140 Cr sits inside the business at any moment.
FY26: debtors at 61 days, inventory at 58 days — roughly 1.9 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 34 days, tighter than FY21's 34.
The full loop: cash goes out to suppliers and production on day 0; stock waits 58 days to sell; customers pay about 61 days after that; and suppliers themselves are paid at 86 days — netting out to the 34-day cycle.
In money terms: at FY26 sales of ₹1,508 Cr, each day of the cycle holds about ₹4.1 Cr — so the 34-day loop keeps roughly ₹140 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹85.0 Cr over the last 3 fiscal years against ₹46.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹6.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Esab India Ltd earns a ROCE of 65% in FY26. That is up from a trough of 13% in FY17. Return on invested capital clears the cost of that capital by +50.5 percentage points, so growth here adds value rather than only size. The wiring behind it is 13.7% net margin on 2.16× asset turns.
FY26 ROCE is 65%, recovered from a FY17 trough of 13% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 13.7% net margin × 2.16× asset turns × 1.63× balance-sheet leverage ≈ 48.2% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 62.5% − 12.0% = a +50.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Esab India Ltd carries total debt of ₹3.0 Cr against shareholder equity of ₹429 Cr as of Mar 26, a debt-to-equity of 0.01 — effectively unlevered. On the annual view that ratio went from 0.01 in FY22 to 0.01 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹3.0 Cr against shareholder equity of ₹429 Cr — a debt-to-equity of 0.01. On the annual view, debt-to-equity went from 0.01 (FY22) to 0.01 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Esab India Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.1 points over the same window, to 1.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: −0.2 points over 8 quarters to 12.9%; Foreign institutions: +0.1 points over 8 quarters to 1.6%; Promoters: +0.0 points over 8 quarters to 73.7%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Esab India Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Ador Welding LtdADOR | 75.0/100Favorable setup71% evidence | LEADER | 24.4/35 Revenue 8.3% · PAT 100% · OPM change 13.8 pp 71% evidence | 19.5/25 ROCE 22.8% · OPM 12% 76% evidence | 11.1/20 P/E 23.1× · PEG — 35% evidence | 20.0/20 RS sector 13.8% · RS bench 38.1% · 1Y 51.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24.4 + 19.5 + 11.1 + 20 = 75 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Diffusion Engineers LtdDIFFNKG | 57.4/100Mixed-positive evidence71% evidence | BREAKING OUT | 26.1/35 Revenue 26.7% · PAT 34.1% · OPM change 0 pp 95% evidence | 13.3/25 ROCE 16.4% · OPM 13% 95% evidence | 10.0/20 P/E 26.5× · PEG — 0% evidence | 8.0/20 RS sector -8.1% · RS bench 16.4% · 1Y 25%10 of 10 weeks ahead 70% evidence |
| Exact sum: 26.1 + 13.3 + 10 + 8 = 57.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Esab India Ltdthis pageESABINDIA | 51.4/100Mixed-positive evidence97% evidence | ASLEEP | 22.1/35 Revenue 13% · PAT 29.8% · OPM change 2 pp 100% evidence | 19.7/25 ROCE 64.7% · OPM 19% 100% evidence | 4.6/20 P/E 46.3× · PEG 4.95 85% evidence | 5.0/20 RS sector -11.2% · RS bench 8.4% · 1Y 20.1%2 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 19.7 + 4.6 + 5 = 51.4 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Esab India Ltd's share price today?
Esab India Ltd trades at ₹6,232, +24.4% over the past year. The company is valued at ₹9,593 Cr. The stock sits at 64% of its 52-week range of ₹4,762–₹7,053, +8.8% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 15 weeks in. — as of 14 August 2026.
What were Esab India Ltd's latest quarterly results?
Esab India Ltd reported revenue of ₹421 Cr and net profit of ₹56.0 Cr for the Jun 26 quarter. Revenue rose 19.6% and profit rose 36.6% year on year. Earnings per share were ₹36.47. The operating margin was 19.0%, 2.0 pp higher than a year earlier. — as of 14 August 2026.
What is Esab India Ltd's revenue?
Esab India Ltd reported revenue of ₹421 Cr in the Jun 26 quarter, +19.6% year on year. For the full FY26 fiscal year, revenue was ₹1,508 Cr (+9.8%). Over the last 10 years revenue compounded at 12.8% a year. — as of 14 August 2026.
What is Esab India Ltd's profit?
Esab India Ltd earned ₹56.0 Cr of net profit in the Jun 26 quarter, +36.6% year on year. Full-year FY26 profit was ₹207 Cr. The operating margin ran 19.0% in the latest quarter. — as of 14 August 2026.
What is Esab India Ltd's market cap?
Esab India Ltd's market capitalisation is ₹9,593 Cr at a share price of ₹6,232. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is Esab India Ltd's P/E ratio?
Esab India Ltd trades at a P/E of 46.3×, at the 60th percentile of its own 11-year range, against a long-run median of 43.7×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does Esab India Ltd pay a dividend?
Yes — Esab India Ltd's dividend payout was 56% of profit in FY26, and it recorded a payout in 15 of its last 16 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 14 August 2026.
Is Esab India Ltd overvalued?
On its own history, Esab India Ltd looks mid-range: its P/E of 46.3× sits at the 60th percentile of its 11-year range (long-run median 43.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.
Is Esab India Ltd growing?
Yes — Esab India Ltd is growing: latest-quarter revenue +19.6% year on year, profit +36.6%, and the margin +2.0 pp at 19.0%. The 10-year compound rates are 12.8% (revenue) and 22.1% (profit). The earnings engine currently reads: improving — as of 14 August 2026.
How is Esab India Ltd performing?
Esab India Ltd is in a confirmed uptrend, 15 weeks in. Its latest quarter's revenue rose 19.6% and profit rose 36.6% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 14 August 2026.
What stage is Esab India Ltd in?
Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 66.7% and holding. The read comes from the last 12 quarters of growth (revenue growth +13.0% latest, profit growth +29.8% latest, eps growth +29.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 14 August 2026.
Is Esab India Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 15 of stage 2), trading +8.8% versus its 200-day average and at 64% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is Esab India Ltd beating the market?
On recent form, yes — Esab India Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +913% against the NIFTY 500's +270% — ahead of the index over the full window. — as of 14 August 2026.
Will Esab India Ltd's share price go up?
This page publishes no price forecast for Esab India Ltd. What it measures instead: the share price is ₹6,232, the price is in a confirmed uptrend 15 weeks in. Its P/E of 46.3× sits at the 60th percentile of its own 11-year range. — as of 14 August 2026.
Who owns Esab India Ltd?
Promoters hold 73.7% of Esab India Ltd, foreign institutions 1.6%, domestic institutions 12.9% and the public 11.8% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 14 August 2026.
Does Esab India Ltd have too much debt?
No — Esab India Ltd's debt-to-equity is 0.01, and operating profit covers the interest bill 90×. FY26 borrowings were ₹3.0 Cr against equity of ₹429 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.
What is Esab India Ltd's capex?
Esab India Ltd spent ₹85.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹26.0 Cr, with ₹6.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is Esab India Ltd's cash flow?
Esab India Ltd generated ₹181 Cr of operating cash flow in FY26 and ₹155 Cr of free cash flow after ₹26.0 Cr of capital spending. Reported profit that year was ₹207 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 14 August 2026.
Is Esab India Ltd's profit real cash?
Yes — over the last 3 fiscal years, 96% of Esab India Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹181 Cr against reported profit of ₹207 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 14 August 2026.
Where is Esab India Ltd in its business cycle?
Esab India Ltd's FY26 operating margin was 18.0%, against a 16-year band of 8.0%–24.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 19.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What could break the Esab India Ltd story?
Biggest watch item: the price is already 15 weeks into its uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is Esab India Ltd a stock worth studying right now?
This is not investment advice. The machine read: Esab India Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.